Published in Eur J Clin Microbiol Infect Dis on March 02, 2012
Implementation of an HPV vaccination program in Eldoret, Kenya: results from a qualitative assessment by key stakeholders. BMC Public Health (2015) 0.81
Facilitators and barriers HPV unvaccinated girls after 5 years of program implementation. Hum Vaccin Immunother (2014) 0.81
Young Hungarian Students' Knowledge about HPV and Their Attitude Toward HPV Vaccination. Vaccines (Basel) (2016) 0.75
Knowledge and early adoption of the HPV vaccine among girls and young women: results of a national survey. J Adolesc Health (2009) 3.13
The burden of genital warts: a study of nearly 70,000 women from the general female population in the 4 Nordic countries. J Infect Dis (2007) 2.14
Knowledge of human papillomavirus and attitudes to vaccination among Swedish high school students. Int J STD AIDS (2009) 2.02
Awareness, knowledge, and beliefs about human papillomavirus in a racially diverse sample of young adults. J Adolesc Health (2007) 1.85
Mothers' and adolescents' beliefs about risk compensation following HPV vaccination. J Adolesc Health (2008) 1.40
"Is cancer contagious?": Australian adolescent girls and their parents: making the most of limited information about HPV and HPV vaccination. Vaccine (2010) 1.39
Human papillomavirus and vaccination: knowledge, attitudes, and behavioural intention in adolescents and young women in Italy. Br J Cancer (2008) 1.27
Adults' knowledge and behaviors related to human papillomavirus infection. J Am Board Fam Pract (2004) 1.27
Young adults and acceptance of the human papillomavirus vaccine. Public Health (2008) 1.21
Epidemiology and pathology of HPV disease in males. Gynecol Oncol (2010) 1.15
Knowledge and acceptability of the HPV vaccine by school children and their parents in Birmingham. Vaccine (2009) 1.12
Knowledge of human papillomavirus infection and its prevention among adolescents and parents in the greater Milan area, Northern Italy. BMC Public Health (2010) 1.03
Most parents do not think receiving human papillomavirus vaccine would encourage sexual activity in their children. J Low Genit Tract Dis (2010) 1.03
Human papillomavirus and cervical cancer: Gardasil vaccination status and knowledge amongst a nationally representative sample of Australian secondary school students. Vaccine (2010) 1.01
Knowledge, attitudes, and informational behaviors of college students in regard to the human papillomavirus. J Am Coll Health (2009) 0.95
Pap smear knowledge among young women following the introduction of the HPV vaccine. J Pediatr Adolesc Gynecol (2009) 0.91
Attitudes towards HPV immunization of Italian mothers of adolescent girls and potential role of health professionals in the immunization program. Vaccine (2009) 0.90
Communication skills in HPV prevention: an audit among Italian healthcare workers. Vaccine (2010) 0.83
Awareness of human papillomavirus in 23 000 Danish men from the general male population. Eur J Cancer Prev (2009) 0.79
HPV knowledge in Mexican college students: implications for intervention programmes. Health Soc Care Community (2010) 0.79
Secondary school students knowledge and awareness of HPV infections and vaccine. Prev Med (2010) 0.77
[Knowledge of HPV-related genital lesions and of anti-HPV vaccination in a sample of women of north-eastern Italy]. Minerva Ginecol (2009) 0.75
Ki67 antigen immunostaining (MIB 1 monoclonal antibody) in serous ovarian tumors: index of proliferative activity with prognostic significance. Gynecol Oncol (1995) 1.25
Laparoscopic colorectal resection for endometriosis. Surg Endosc (2005) 0.96
Oral discomfort and hormone replacement therapy in the post-menopause. Maturitas (1991) 0.89
Tissue and serum metalloproteinase (MMP-2) expression in advanced ovarian serous cystoadenocarcinomas: clinical and prognostic implications. Anticancer Res (1996) 0.89
Expression of vascular endothelial growth factor related to 72-kilodalton metalloproteinase immunostaining in patients with serous ovarian tumors. Cancer (1999) 0.88
Sclerosing stromal tumor of the ovary: US, CT, and MRI findings. Abdom Imaging (2002) 0.88
Relationship between 17-beta-estradiol and prolactin in the regulation of natural killer cell activity during progression of endometriosis. J Endocrinol Invest (1995) 0.88
Identification of six putative novel human papillomaviruses (HPV) and characterization of candidate HPV type 87. J Virol (2001) 0.88
Vascular endothelial growth factor expression as a prognostic index in serous ovarian cystoadenocarcinomas: relationship with MIB1 immunostaining. Gynecol Oncol (1999) 0.87
Hysteroscopic permanent tubal sterilization using a nitinol-dacron intratubal device without anaesthesia in the outpatient setting: procedure feasibility and effectiveness. Hum Reprod (2005) 0.87
Natural killer cell activity in endometriosis: correlation between serum estradiol levels and cytotoxicity. Obstet Gynecol (1993) 0.86
The role of human papillomavirus DNAs in cervical carcinoma and risk of lymph node metastasis: association with 72-kilodalton metalloproteinase immunostaining. Cancer (1998) 0.85
Detection and typing of human papillomavirus in histologic specimens by in situ hybridization with biotinylated DNA probes. Am J Clin Pathol (1989) 0.84
72-kilodalton type IV collagenase, type IV collagen, and Ki 67 antigen in serous tumors or the ovary: a clinicopathologic, immunohistochemical, and Serological study. Int J Gynecol Pathol (1996) 0.83
HPV DNA positivity and natural killer cell activity in the clinical outcome of mild cervical dysplasia: integration between virus and immune system. Gynecol Obstet Invest (1995) 0.83
Predictors of malignancy in endometrial polyps: a multi-institutional cohort study. Eur J Gynaecol Oncol (2014) 0.82
Cervical dysplasia in HIV-seropositive women: role of human papillomavirus infection and immune status. Gynecol Obstet Invest (1995) 0.80
Natural killer cell activity in stage I endometrial carcinoma: correlation with nuclear grading, myometrial invasion, and immunoreactivity of proliferating cell nuclear antigen. Gynecol Oncol (1994) 0.80
Natural cytotoxicity and GnRH agonist administration in advanced endometriosis: positive modulation on natural killer activity. Obstet Gynecol (1996) 0.80
Role of zinc and alpha2 macroglobulin on thymic endocrine activity and on peripheral immune efficiency (natural killer activity and interleukin 2) in cervical carcinoma. Br J Cancer (1999) 0.80
Chlamydia trachomatis infections in asymptomatic women. Results of a study employing different staining techniques. Acta Cytol (1989) 0.80
Expression of estrogen receptor in hemangioma of the uterine cervix: reports of three cases and review of the literature. Arch Gynecol Obstet (2009) 0.80
Treatment patterns and associated costs for genital warts in Italy. Curr Med Res Opin (2008) 0.80
The 72-kDa metalloproteinase immunostaining in cervical carcinoma: relationship with lymph nodal involvement. Gynecol Oncol (1996) 0.79
Natural killer cell activity in patients with invasive cervical carcinoma: importance of a longitudinal evaluation in follow-up. Gynecol Obstet Invest (1995) 0.79
Improvement of Pap smear sensitivity using a visual adjunctive procedure: a co-operative Italian study on speculoscopy (GISPE). Eur J Cancer Prev (1998) 0.78
Natural killer cell activity and progression-free survival in ovarian cancer. Gynecol Obstet Invest (1993) 0.78
Patients' perspectives on the burden of recurrent genital herpes. Int J STD AIDS (2001) 0.78
Natural killer cell activity in patients with gynecologic malignancies: correlation with histologic grading and stage of disease. Gynecol Obstet Invest (1992) 0.78
High-grade vaginal intraepithelial neoplasia and risk of progression to vaginal cancer: a multicentre study of the Italian Society of Colposcopy and Cervico-Vaginal Pathology (SICPCV). Eur Rev Med Pharmacol Sci (2016) 0.78
Proliferating cell nuclear antigen in endometrial carcinoma: pretreatment identification of high-risk patients. Gynecol Oncol (1996) 0.78
Serum CA-125 concentration in endometriosis patients: role of pelvic and peritoneal irritation. Gynecol Endocrinol (1994) 0.78
The relationship of clinical-pathologic status and adjuvant treatment with natural killer cell activity in stage I and II endometrial carcinoma. Acta Obstet Gynecol Scand (1994) 0.77
Increased serum 72 KDa metalloproteinase in serous ovarian tumors: comparison with CA 125. Anticancer Res (1996) 0.77
Giant cell tumor of the hamate bone. Chir Organi Mov (1990) 0.77
MIB 1 immunostaining in stage I squamous cervical carcinoma: relationship with natural killer cell activity. Gynecol Oncol (1995) 0.77
Microinvasive cervical carcinoma and cervical intraepithelial neoplasia: biologic significance and clinical implications of 72-kDa metalloproteinase immunostaining. Gynecol Oncol (1996) 0.77
High temperature requirement A1, transforming growth factor beta1, phosphoSmad2 and Ki67 in eutopic and ectopic endometrium of women with endometriosis. Eur J Histochem (2015) 0.76
In vivo amifostine (WR-2721) prevents chemotherapy-induced apoptosis of peripheral blood lymphocytes from cancer patients. Life Sci (1999) 0.76
[Tumor markers in the early diagnosis of recurrence in gynecologic neoplasms: combined determination of CA-125, CA 15-3, CA 72.4, SCC, 90 K]. Ann Ostet Ginecol Med Perinat (1992) 0.76
Modulation of expression of p53 and cell proliferation in locally advanced cervical carcinoma after neoadjuvant combination chemotherapy. Eur J Obstet Gynecol Reprod Biol (1995) 0.76
Expression of p53 and apoptosis of tumor cells in locally advanced cervical carcinoma after cisplatin based neoadjuvant chemotherapy. Anticancer Res (1996) 0.76
Natural killer activity in stage III and IV endometriosis: impaired cytotoxicity and retained lymphokine responsiveness of natural killer cells. Gynecol Endocrinol (1995) 0.76
Decrease in peripheral blood polymorphonuclear leukocyte chemotactic index in endometriosis: role of prostaglandin E2 release. Obstet Gynecol (1998) 0.76
Baseline apoptosis of tumor cells as a response predictor to chemotherapy. J Natl Cancer Inst (1997) 0.75
Immuno-biologic integration for therapeutic approach in ovarian carcinoma. Eur J Gynaecol Oncol (1992) 0.75
Age-related changes in the diagnostic assessment of women with severe cervical lesions. Climacteric (2015) 0.75
Combined ultrasonographically guided drainage and laparoscopic excision of large endometriomas: a pilot study. Gynecol Obstet Invest (1998) 0.75
Prevalence of different types of human papillomavirus in cervical infection of north Italian women. Eur J Obstet Gynecol Reprod Biol (1991) 0.75
Ras p21 immunostaining in early stage squamous cervical carcinoma: relationship with lymph nodal involvement and 72 kDa-metalloproteinase index. Anticancer Res (1998) 0.75
[Study of the blood vessels in colposcopy]. Minerva Ginecol (1986) 0.75
Simple and complex dislocations of the carpus. Ital J Orthop Traumatol (1989) 0.75
p53 immunostaining and HPV DNA detection by PCR in cervical intraepithelial neoplasia: clinical implications of a combinated evaluation. Anticancer Res (1997) 0.75
Lymphocyte subset in HPV infection. Eur J Gynaecol Oncol (1992) 0.75
Efficacy of the association of 13-cis-retinoic acid (13cRA) and alpha-interferon 2a (alpha-IFN 2a) in moderate-severe cervical intraepithelial neoplasia (CIN II-III): a pilot study. Anticancer Res (1996) 0.75
Interferon alpha 2b treatment of cervical intraepithelial neoplasia grade 2: modulation of natural killer cell. Gynecol Obstet Invest (1994) 0.75
Correlation between estradiol serum levels and NK cell activity in endometriosis. Ann N Y Acad Sci (1994) 0.75
Carcinoma of the cervix in pregnancy. Case report. Eur J Gynaecol Oncol (1993) 0.75
Recurrence patterns in locally advanced cervical carcinoma: role of nodal status and 72-kDa metalloproteinase index. Gynecol Oncol (1996) 0.75
Decrease of cellular growth potential in "in vitro" culture of amnions with premature rupture of membranes. Clin Exp Obstet Gynecol (1992) 0.75
Longitudinal measurement of amniotic fluid index in term pregnancies and its association with intrapartum fetal distress. Gynecol Obstet Invest (1997) 0.75
Lymphocyte subset and NK activity in cervical intra-epithelial neoplasia. Gynecol Obstet Invest (1992) 0.75
Cisplatin, epirubicin and cyclophosphamide (PEC) in the treatment of advanced ovarian cancer. J Exp Clin Cancer Res (2000) 0.75
MIB 1 immunostaining in cervical carcinoma of young patients. Gynecol Oncol (1997) 0.75
A case of segmental renal dysplasia incidentally discovered in an 18 year old woman during a gynecological surgical operation. Clin Exp Obstet Gynecol (1992) 0.75
Risk of recurrent menorrhagia after hydrothermoablation: role of GnRH analogues neoadjuvant treatment in long-term successful rate. Clin Exp Obstet Gynecol (2014) 0.75
Vaginal micropapillary lesions are not related to human papillomavirus infection: in situ hybridization and polymerase chain reaction detection techniques. Gynecol Obstet Invest (1994) 0.75
Vulvar intraepithelial neoplasia. A clinicopathologic study of 60 cases. J Reprod Med (1990) 0.75
[Preoperative platelet count as index of the grading in endometrial carcinoma]. Minerva Ginecol (2008) 0.75
Antibodies to papillomavirus genus-antigens in women with genital warts. Microbiologica (1987) 0.75
[Transvaginal echography in the evaluation of the grade of myometrial invasion in locally advanced endometrial carcinoma]. Ann Ostet Ginecol Med Perinat (1993) 0.75
Endometrioid carcinoma arising in endometriosis. Case report. Eur J Gynaecol Oncol (1992) 0.75
[Homologous intrauterine insemination: our experience]. Ann Ostet Ginecol Med Perinat (1993) 0.75
Prophylactic transabdominal amnioinfusion in oligohydramnios for preterm premature rupture of membranes: increase of amniotic fluid index during latency period. Gynecol Obstet Invest (1997) 0.75
[Platelet antiaggregation and anticoagulant drugs in the treatment of proliferative glomerulonephritis in children]. Minerva Pediatr (1979) 0.75
Immunitary system in pregnancy hypertension. Acta Eur Fertil (1992) 0.75
Endometrioid carcinoma of the ovary. Retrospective study. Eur J Gynaecol Oncol (1993) 0.75
[Prognostic significance of diagnostic delay in carcinoma of the endometrium: our experience]. Ann Ostet Ginecol Med Perinat (1993) 0.75
Influence of neoadjuvant polychemotherapy on natural killer cell activity in patients with locally advanced cervical squamous carcinoma. Gynecol Oncol (1994) 0.75
Nodal immune reactivity in FIGO (International Federation of Gyn-Ob) Stage I endometrial carcinoma: relationship with myometrial invasion. Acta Obstet Gynecol Scand (1995) 0.75
[Disgerminoma of the ovary. Anatomo-prognostic correlations in 26 cases]. Ann Ostet Ginecol Med Perinat (1982) 0.75
MIB 1 immunostaining in cervical intraepithelial neoplasia: prognostic significance in mild and moderate lesions. Gynecol Obstet Invest (1996) 0.75
Is CT scan monitoring useful in patients with epithelial ovarian cancer and follow-up negative CA 125 serum levels? Oncol Rep (2011) 0.75
[Knowledge of HPV-related genital lesions and of anti-HPV vaccination in a sample of women of north-eastern Italy]. Minerva Ginecol (2009) 0.75
[Report on one year of clinical activity of the coronary unit of the resuscitation department of the Policlinico Universitario of Milan]. Boll Soc Ital Cardiol (1970) 0.75
Colposcopic patterns of vaginal intraepithelial neoplasia: a focus on low-grade lesions. Eur Rev Med Pharmacol Sci (2017) 0.75